Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tango Therapeutics (TNGX) Cash from Financing Activities (2020 - 2025)

Tango Therapeutics has reported Cash from Financing Activities over the past 6 years, most recently at $219.4 million for Q4 2025.

  • For Q4 2025, Cash from Financing Activities rose 22539.42% year-over-year to $219.4 million; the TTM value through Dec 2025 reached $222.5 million, up 366.81%, while the annual FY2025 figure was $222.5 million, 366.81% up from the prior year.
  • Cash from Financing Activities for Q4 2025 was $219.4 million at Tango Therapeutics, up from $2.5 million in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $327.8 million in Q3 2021 and troughed at -$746000.0 in Q2 2021.
  • A 5-year average of $35.6 million and a median of $843500.0 in 2022 define the central range for Cash from Financing Activities.
  • Biggest five-year swings in Cash from Financing Activities: tumbled 3081.02% in 2021 and later surged 70944.25% in 2023.
  • Year by year, Cash from Financing Activities stood at -$120000.0 in 2021, then surged by 539.17% to $527000.0 in 2022, then soared by 178.37% to $1.5 million in 2023, then tumbled by 33.95% to $969000.0 in 2024, then surged by 22539.42% to $219.4 million in 2025.
  • Business Quant data shows Cash from Financing Activities for TNGX at $219.4 million in Q4 2025, $2.5 million in Q3 2025, and $581000.0 in Q2 2025.